GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Lupin Ltd (NSE:LUPIN) » Definitions » Additional Paid-In Capital

Lupin (NSE:LUPIN) Additional Paid-In Capital : ₹0 Mil(As of Mar. 2024)


View and export this data going back to 2001. Start your Free Trial

What is Lupin Additional Paid-In Capital?


Lupin's annual additional paid-in capital increased from Mar. 2022 (₹10,747 Mil) to Mar. 2023 (₹11,202 Mil) but then declined from Mar. 2023 (₹11,202 Mil) to Mar. 2024 (₹0 Mil).


Lupin Additional Paid-In Capital Historical Data

The historical data trend for Lupin's Additional Paid-In Capital can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lupin Additional Paid-In Capital Chart

Lupin Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Additional Paid-In Capital
Get a 7-Day Free Trial Premium Member Only Premium Member Only 9,301.90 10,013.60 10,746.90 11,202.30 -

Lupin Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Additional Paid-In Capital Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 11,202.30 - - - -

Lupin Additional Paid-In Capital Calculation

Capital that a company raises in a financing round in excess of the capital's par value. The account represents the excess paid by an investor over the par-value price of a stock issue. Additional paid-in-capital can arise from issuing either preferred or common stock.

Additional Paid-In Capital is calculated as

Additional Paid-In Capital=(Issue Price-Par Value)* Shares Outstanding (Diluted Average)

Lupin Additional Paid-In Capital Related Terms

Thank you for viewing the detailed overview of Lupin's Additional Paid-In Capital provided by GuruFocus.com. Please click on the following links to see related term pages.


Lupin (NSE:LUPIN) Business Description

Traded in Other Exchanges
Address
Off. Western Express Highway, 3rd floor, Kalpataru Inspire, Santacruz (East), Mumbai, MH, IND, 400 055
Lupin Ltd is a specialty and generic drug manufacturing company. The company's global formulations business develops and delivers a wide range of branded and generic formulations across the globe. The operations of the company are limited to one segment, namely pharmaceuticals and related products. The company also maintains a pipeline in high-barrier markets such as Inhalation, Biosimilars and Complex Injectables. The vast majority of the company's sales are generated in the United States, followed by India.

Lupin (NSE:LUPIN) Headlines

No Headlines